I haven't really had time to research them. I believe Neon is running or has run a preliminary trial. I think we have the advantage of our listeria platform but there will be more competition as time goes on. Neoantigens look to have a bright future if it all pans out and we're among the first to be trying them and backed by Amgen.
News 
Market Data 
Discover 
AI
